Medline MDLN

Medical - Instruments & Supplies, Healthcare

$34.09

−2.26%

Market cap: $44.8B
PE: n/m; one or more of the four quarters through 2026-06-27 missing
Forward PE: 23.2×
Price to sales: n/m; one or more of the four quarters through 2026-06-27 missing
EV/EBIT: n/m; a loss over the last year
Revenue, 12 months: n/m; one or more of the four quarters through 2026-06-27 missing
Net margin: n/m; one or more of the four quarters through 2026-06-27 missing
Free cash flow yield: n/m; not a meaningful number

Charts

Financials

Income statement for MDLN, by quarter
Income statement	Q1 FY25	Q2 FY25	Q1 FY26	Q2 FY26
	$6.6B	$6.9B	$7.4B	$7.7B
Cost of revenue	$4.8B	$5B	$5.5B	$5.5B
Gross profit	$1.8B	$1.9B	$1.8B	$2.2B
SG&A	$1.1B	$1.1B	$1.2B	$1.3B
	$571M	$642M	$422M	$395M
Interest expense	$244M	$253M	$165M	$168M
Pre-tax income	$338M	$359M	$291M	$235M
	$16M	$26M	$52M	$96M
Net income	n/a	n/a	$132M	$59M
	n/a	n/a	$0.16	$0.07
	n/a	n/a	825M	861M

Net income: Q1 FY26 and Q2 FY26: not printed by the filing, worked out from its own lines.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Estimates

Next earnings report: Nov 4, 2026.

Quarter	Revenue	Range	EPS	Range	Analysts
Q3 FY26	$7.7B	$7.7B to $7.7B	$0.34	$0.32 to $0.35	15
Q4 FY26	$8.5B	$8.4B to $8.5B	$0.40	$0.37 to $0.43	14
Q1 FY27	$7.9B	$7.8B to $7.9B	$0.34	$0.34 to $0.35	6
Q2 FY27	$8.3B	$8.2B to $8.4B	$0.38	$0.38 to $0.38	11
Q3 FY27	$8.3B	$8.2B to $8.4B	$0.40	$0.40 to $0.41	6
Q4 FY27	$9.2B	$9.1B to $9.3B	$0.46	$0.46 to $0.47	9
Q1 FY28	$8.4B	$8.3B to $8.5B	$0.37	$0.36 to $0.37	10
Q2 FY28	$8.9B	$8.8B to $9B	$0.42	$0.42 to $0.43	7

Peers

Companies in Medical - Instruments & Supplies nearest Medline's size, closest first.

Company	Market cap	PE	Its 10y median PE	Fwd PE	P/S	Revenue growth	Net margin
MDLNMedline	$44.8B	n/m	n/a	23.2×	n/m	n/m	n/m
BDXBecton, Dickinson and	$54.2B	60.1×	37.5×	15.1×	2.6×	+5%	4.5%
RMDResMed	$36.5B	24.2×	37.3×	20.8×	6.5×	+10%	26.9%
WSTWest Pharmaceutical Services	$27.6B	50.2×	45.8×	42.2×	8.3×	+12%	17.0%
SOLVSolventum	$14.5B	10.4×	10.7×	n/m	1.7×	−1%	17.3%
PENPenumbra	$12.8B	79.7×	197×	n/m	8.5×	+18%	10.7%
ISRGIntuitive Surgical	$159.8B	54.7×	69.3×	37.5×	13.8×	+20%	25.5%
COOCooper Companies	$11.6B	20.9×	40.2×	n/m	2.7×	+5%	13.5%
ALGNAlign Technology	$11B	26.9×	43.3×	n/m	2.7×	+4%	10.0%
GMEDGlobus Medical	$10.9B	20.8×	37.4×	n/m	3.5×	+20%	17.0%
PODDInsulet	$10.3B	27.9×	63.0×	n/m	3.4×	+29%	12.3%
Peer median	$13.7B	27.4×	41.8×	29.2×	3.4×	+11%	15.2%